Stay updated on Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page revision updated to v3.6.3, signaling a new build of the page. This change does not modify the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-07-03T13:34:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a version update. This change updates metadata without altering study information or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-06-26T10:25:28.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Adds a recruitment status note No longer looking for participants and introduces new Help/Navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); also updates the Intervention/Treatment header formatting.
    Difference
    0.1%
    Check dated 2026-06-11T22:49:53.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.4 to v3.5.5, signaling a new version of the document. This appears to be a metadata update rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-06-04T20:46:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.3 to v3.5.4, with a new revision line added and the previous one removed.
    Difference
    0.0%
    Check dated 2026-05-21T15:29:38.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The Taiwan site listing was changed from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333 to reflect the correct city designation for the study site.
    Difference
    0.0%
    Check dated 2026-05-07T09:20:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Renal Cell Carcinoma Adjuvant Clinical Trial page.